North America Digital Biomarkers Market Size & Outlook

The digital biomarkers market in North America is expected to reach a projected revenue of US$ 7,751.2 million by 2030. A compound annual growth rate of 21.4% is expected of North America digital biomarkers market from 2024 to 2030.
Revenue, 2023 (US$M)
$1,997.4
Forecast, 2030 (US$M)
$7,751.2
CAGR, 2024 - 2030
21.4%
Report Coverage
North America

North America digital biomarkers market highlights

  • The North America digital biomarkers market generated a revenue of USD 1,997.4 million in 2023.
  • The market is expected to grow at a CAGR of 21.4% from 2024 to 2030.
  • In terms of segment, wearable was the largest revenue generating type in 2023.
  • Mobile based Applications is the most lucrative type segment registering the fastest growth during the forecast period.
  • Country-wise, Canada is expected to register the highest CAGR from 2024 to 2030.


North America data book summary

Market revenue in 2023USD 1,997.4 million
Market revenue in 2030USD 7,751.2 million
Growth rate21.4% (CAGR from 2023 to 2030)
Largest segmentWearable
Fastest growing segmentMobile based Applications
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationWearable, Mobile based Applications, Sensors
Key market players worldwideAmgen Inc, Biogen Inc, Pfizer Inc, ActiGraph, AliveCor, Koneksa Health, Altoida, Empatica, VivoSense, Ixico, Neurotrack, Aural Analytics, Sonde Health, Clario, Imagene AI, Brainomix, Kinsa, Feel Therapeutics


Other key industry trends

  • In terms of revenue, North America region accounted for 58.4% of the global digital biomarkers market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Europe is the fastest growing regional market and is projected to reach USD 3,585.1 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Digital Biomarkers Market Scope

Digital biomarkers market segmentation & scope
Wearable
Mobile based Applications
Sensors
Others
Diagnostic digital biomarkers
Monitoring digital biomarkers
Predictive and Prognostic digital biomarkers
Others
Cardiovascular and metabolic disorders (CVMD)
Respiratory disorders
Psychiatric disorders
Sleep & Movement Disease
Neurological disorders
Musculoskeletal disorders
Others
Healthcare companies
Healthcare Providers
Payers
Others

Digital Biomarkers Market Companies

Name Profile # Employees HQ Website

North America digital biomarkers market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to digital biomarkers market will help companies and investors design strategic landscapes.


Wearable was the largest segment with a revenue share of 40.46% in 2023. Horizon Databook has segmented the North America digital biomarkers market based on wearable, mobile based applications, sensors covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to North America digital biomarkers market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of North America digital biomarkers market databook

  • Our clientele includes a mix of digital biomarkers market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the North America digital biomarkers market , including forecasts for subscribers. This continent databook contains high-level insights into North America digital biomarkers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

North America digital biomarkers market size, by country, 2018-2030 (US$M)

North America Digital Biomarkers Market Outlook Share, 2023 & 2030 (US$M)

North America digital biomarkers market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more